Epidemiology of Musculoskeletal Injuries in Male Adult Basketball Athletes in Brazil: A One-season Descriptive Study

巴西成年男性篮球运动员肌肉骨骼损伤的流行病学:一项为期一个赛季的描述性研究

阅读:1

Abstract

INTRODUCTION: Basketball has one of the highest injury rates among team sports, however, published data investigating basketball-related musculoskeletal injuries (BRMIs) in professional players in Brazil are limited. The purpose of this study was to investigate the clinical incidence, rate, location, type(s), severity, and nature of BRMIs in Brazilian professional basketball players, and to quantify their impact on sports performance. STUDY DESIGN: Prospective cohort study. METHODS: Athletes over 18 years old who were registered and active in the professional category of each participating team that signed the Consent Form were included in this study. Over the course of 22 weeks the Team's Physical Therapist collected data weekly through an online questionnaire. The Orchard Sports Injury Classification System (OSICS) was used to provide anatomical and diagnostic classification of BRMIs and the injury severity was evaluated using the Oslo Sports Trauma Research Center questionnaire (OSTRC) score. Qualitative variables were represented by frequency and proportions, and quantitative variables by mean and standard deviation. RESULTS: A total of 103 athletes with a mean age of 28.8 years +/- 5.4 years reported 164 BRMI's with a clinical injury incidence of 1.6 over the 22-week study. Of these, 122 (74.4%) occurred in the lower limbs and 22 (13.4%) in the upper limbs. The BRMI rate was 5.1 injuries per 1,000 hours/practice and 79.6 injuries per 1,000 hours/game. The knee was the most affected area (19.5%), followed by hip/groin (15.2%). Muscle injuries were the most frequent (33.5%) and the most severe (4070 points OSTRC). CONCLUSION: These findings show the importance of implementing injury monitoring measures in basketball using a standardized, low-cost and easy-to-use questionnaire to monitor the impact of BRMIs on practice and game performance. LEVEL OF EVIDENCE: 3b (Epidemiology).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。